ReimbursementIQ – 360-Degree Impact From Volume Through Value™: www.reimbursementiq.com

A Member of the xIQ Family of Companies – Improving Client Performance, Outcomes, and Impacts™: www.xiqfamilyofcompanies.com

ReimbursementIQ provides next-generation analytical services, strategy services, and support services to help chief executive officers and their teams become highly profitable market leaders under U.S. healthcare’s volume-to-value (V2V) transition, focusing on market access, market messaging, and market engagement.

Our Top-3 services are (1) value-documenting patient-support services (e.g., hub services); (2) value-defining messaging analytics, content development, and content syndication services; and (3) value-driving key opinion leader and key outcomes leader (KOL) identification, strategy, and engagement services—all optimized to capture real-world data (RWD) and improve real-world evidence (RWE).

Our tech-savvy team includes data scientists, business strategists, and program design and evaluation specialists—many personally trained by Peter F. Drucker, an advocate of deploying business strategy to create a better functioning society (not just shareholder value), and improving profit as a measure of effectiveness (not just as an endpoint).

Established in 1988 and reacquired from brand-name corporate buyers in 2004, we’re best known for helping BioPharma, MedTech, and HealthTech innovators, entrepreneurs, and executives accelerate their speed to clinical, financial, and market success in—and preemptive leadership of—volume-to-value (V2V) markets through a value-centered approach to market access, market messaging, and market engagement.

We serve chief executive officers (CEOs) and their top strategists in Technology Licensing and Development; Value and Evidence (HEOR/CER/RWE); Medical Affairs; Market Access and Reimbursement; Marketing; and Commercialization Units.

These pioneering individuals understand that healthcare’s power structure—political, economic, and social—is shifting toward health plan purchasers—especially self-insured employers, unions, and other population health decision makers with first-dollar exposure to healthcare costs.

Our clients win by reorienting, retooling, and redeploying to serve the needs of health plan purchasers—a critical new category of customers—even as these customers remain one or two degrees of separation away.

We help our forward-thinking clients (1) guide their organizations through the volume-to-value (V2V) transition into value-based healthcare (VBHC); (2) understand value-based contracts (VBC), outcomes-based compensation (OBC), and 360-degree impact accountability; and (3) become highly profitable, preemptive market leaders through next-generation market access, market messaging, and market engagement.

Our clients come to us because they know we are a tech-savvy analytics, strategy, and support-services firm with unique insight and capabilities around the volume-to-value (V2V) transition and value-based healthcare (VBHC).

They know we are unique in our commitment to helping them become preemptive market leaders by doing what healthcare stakeholders should be doing: reducing the incidence, prevalence, and cost of diseases and other adverse health conditions—a bold but necessary move in a market made dysfunctional by fee-for-service (FFS) reimbursement and self-correcting through value-based payment (VBP) models.

We help these clients profit while (1) accelerating the volume-to-value (V2V) transition through value-based contracts (VBCs), outcomes-based compensation (OBCs), and 360-degree impact-accountable population-health-optimization programs; (2) providing next-generation patient-support solutions (e.g., hub services) so patients benefit more fully from the healthcare industry’s most safe, effective, and cost-saving products and services; and (3) documenting improved economic, clinical, and humanistic outcomes (ECHOs) and Triple/Quadruple Aim successes to elicit evidence-based coverage, coding, and payment policies from health-plan purchasers (e.g., self-insured employers), third-party payers (e.g., commercial and public insurers), and capitated healthcare providers (e.g., accountable care organizations).

In summary, our market access, market messaging, and market engagement analytics, strategies, and support services help innovators, entrepreneurs, and executives in the healthcare, education, and social-service sectors reduce the incidence, prevalence, and cost of diseases and other adverse conditions.

We drive these results by facilitating access to the industry’s most safe, effective, and cost-saving healthcare products, services, and solutions—most subject to health plan purchaser, third-party payer, and captivated healthcare provider coverage, coding, reimbursement, value-based contracting (VBC), and outcomes-based compensation (OBC) policies.

We are best known for our strategic research, content development, and hands-on advocacy work in support of (1) performance-accountable, outcomes-accountable, and impact-accountable healthcare; (2) the Triple/Quadruple Aim of reduced per capita costs, improved population health, and enhanced patient and provider experiences; and (3) a better functioning society.

Remember “RWE for VBC under V2V.” We help you compile real-world data (RWD) and real-world evidence (RWE) for value-based contracts (VBC), outcomes-based compensation (OBC), and U.S. healthcare’s volume-to-value (V2V) transition.

© 2020 ReimbursementIQ, LLC | xIQ Family of Companies | Proprietary Information | All Rights Reserved